The short version of melanocortin receptor fits in a sentence. The long version — which is the one that helps — is below.
This page was last updated on 2025-12-02 and is reviewed periodically as new material appears.
Bremelanotide is a cyclic heptapeptide that binds several melanocortin receptors rather than one. In vitro assays report agonist activity at MC1R, MC3R, MC4R and MC5R, with MC4R generally treated as the subtype most relevant to sexual effects. MC4R is expressed in hypothalamic nuclei involved in appetite, energy balance and motivated behaviour, which provides a plausible route for central action. Selective MC4R agonists studied in animals produce comparable behavioural changes, supporting that interpretation.
How receptor activation translates into a change in desire is not established in detail. Proposed steps include modulation of dopaminergic signalling in reward circuits and downstream effects on autonomic tone. Human data consist mainly of clinical trials measuring self-reported outcomes rather than direct measurements of brain activity or transmitter release. The transient rise in blood pressure sometimes observed after administration is likewise reported consistently but explained only partly by known melanocortin pathways.
Clinical research typically uses randomised, double-blind, placebo-controlled designs. The most common primary endpoint is the desire domain score of the Female Sexual Function Index, sometimes paired with a distress measure. Secondary outcomes include arousal, satisfaction, and event-based counts of satisfying sexual episodes. Across trials, average improvements are modest and individual responses vary widely. Whether benefits persist beyond a few months, and whether they depend on baseline hormone status, remain open questions rather than settled findings.
Melanocortin receptors form a family of five G-protein-coupled receptors designated MC1 through MC5. Bremelanotide binds most strongly at MC4R and MC1R, with weaker activity reported at MC3R and MC5R. MC4R is expressed in hypothalamic nuclei that coordinate energy balance and aspects of sexual behaviour. The prevailing interpretation is that central MC4R activation, rather than peripheral vascular effects alone, drives the reported changes in desire. This account remains partly inferential, since direct receptor-level measurement in living humans is not practical.
After subcutaneous administration, plasma concentrations rise within roughly thirty minutes and the elimination half-life is short, on the order of two to three hours. Reported physiological responses include transient increases in blood pressure and nausea, which tended to diminish with repeated dosing in trial settings. Because the peptide clears quickly, effects are not expected to persist long after a dose. Absorption from non-injected routes is poorly characterised, and nasal delivery produced variable plasma levels in older work.
| Property | Value | Notes |
|---|---|---|
| Primary receptor target | MC4R agonist | Subtype most often linked to behavioural effects |
| Other reported targets | MC1R, MC3R, MC5R | Activity is not selective for a single subtype |
| Endogenous ligand class | Melanocortin peptides | Alpha-MSH and ACTH act on the same family |
| Peptide architecture | Cyclic heptapeptide | Lactam bridge between the aspartate and lysine residues |
| Central action | Inferred from animal models | Not directly measured in the human brain |
The lactam ring that closes the peptide backbone improves resistance to exopeptidase attack, but the molecule stays susceptible to hydrolysis and oxidation once dissolved. Degradation accelerates with temperature, extreme pH, and light exposure, and repeated freeze-thaw cycles promote aggregation and material loss. Lyophilized powder held desiccated at or below minus twenty degrees Celsius is the common way to keep reference material. Reconstituted solutions are generally kept cold and used within a short window because their stability is far lower than that of the dry solid.
Handling procedures emphasize minimizing moisture uptake, since the dried solid is hygroscopic and can draw water when warmed to room temperature before a vial is opened. Laboratories record lot number, purity, counter-ion content, and residual solvent data supplied by the producer. Impurity profiles are compared run to run, and any shift in retention time or peak shape prompts re-verification against a reference standard. Certificates of analysis are treated as claims to be checked rather than accepted at face value.
Bremelanotide acts as a non-selective agonist at melanocortin receptors, with reported activity at MC1R, MC3R, MC4R and MC5R. The proposed basis for its central effects is activation of MC4R populations in the hypothalamus, a region associated with appetite and reproductive signalling. Because the peptide carries a net positive charge and polar side chains, it does not cross biological membranes freely, which is one reason oral administration is not the standard route. Effects generally appear within an hour of parenteral administration and are described as centrally mediated rather than peripheral.
Bremelanotide, developed under the code PT-141, is a synthetic cyclic heptapeptide analogue of alpha-melanocyte-stimulating hormone. Its structure is Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH, with a lactam bridge joining the aspartate and lysine side chains. The molecule has the formula C50H68N14O10 and a monoisotopic mass near 1025 daltons. It is commonly prepared as the acetate salt and appears as a white to off-white lyophilised powder in solid form. The free acid is the pharmacologically relevant species, while the counter-ion improves handling and dissolution.
== Modern definitions == In broad metaphorical (colloquial) usage of the term, "poison" may refer to anything deemed harmful. In biology, poisons are substances that can cause death, injury, or harm to organs, tissues, cells, and DNA usually by chemical reactions or other activity on the molecular scale, when an organism is exposed to a sufficient quantity. Medicinal fields (particularly veterinary medicine) and zoology often distinguish poisons from toxins and venoms. Both poisons and venoms are toxins, which are toxicants produced by organisms in nature. The difference between venom and poison is the delivery method of the toxin. Venoms are toxins that are actively delivered by being injected via a bite or sting through a venom apparatus, such as fangs or a stinger, in a process called envenomation, whereas poisons are toxins that are passively delivered by being swallowed, inhaled, or absorbed through the skin. Unantidoteable refers to toxins that cannot be neutralized by modern medical technology, regardless of their type.
== MSP nanodisc == The original nanodisc was produced by apoA1-derived MSPs from 2002. The size and stability of these discs depend on the size of these proteins, which can be adjusted by truncation and fusion. In general, MSP1 proteins consist of one repeat, and MSP2s are double-sized.
lymph nodes and the spleen) maintain mature naive T cells and naive B cells; initiate the adaptive immune response; and are the sites of lymphocyte activation by antigens, which leads to clonal selection and affinity maturation.
Supercritical CO2 can be used as a working fluid for geothermal electricity generation in both enhanced geothermal systems and sedimentary geothermal systems (so-called CO2 Plume Geothermal). EGS systems utilize an artificially fractured reservoir in basement rock while CPG systems utilize shallower naturally-permeable sedimentary reservoirs. Possible advantages of using CO2 in a geologic reservoir, compared to water, include higher energy yield resulting from its lower viscosity, better chemical interaction, and permanent CO2 storage as the reservoir must be filled with large masses of CO2. As of 2011, the concept had not been tested in the field.
He said: "Can it be so abstract that it becomes genuinely beautiful? ...really aesthetically beautiful even if someone is having their cheek blown out or their head crushing into concrete." Comic artist Jock provided concept art for the film design.
Sources: en.wikipedia.org
Isobaric tags for relative and absolute quantitation (iTRAQ) is an isobaric labeling method used in quantitative proteomics by tandem mass spectrometry to determine the amount of proteins from different sources in a single experiment. It uses stable isotope labeled molecules that can be covalent bonded to the N-terminus and side chain amines of proteins.
== Patents == Although details have not surfaced, it appears that the University of Utah forced the 23 March 1989 Fleischmann and Pons announcement to establish priority over the discovery and its patents before the joint publication with Jones. The Massachusetts Institute of Technology (MIT) announced on 12 April 1989 that it had applied for its own patents based on theoretical work of one of its researchers, Peter L. Hagelstein, who had been sending papers to journals from 5 to 12 April. An MIT graduate student applied for a patent but was reportedly rejected by the USPTO in part by the citation of the "negative" MIT Plasma Fusion Center's cold fusion experiment of 1989. On 2 December 1993 the University of Utah licensed all its cold fusion patents to ENECO, a new company created to profit from cold fusion discoveries, and in March 1998 it said that it would no longer defend its patents. The U.S. Patent and Trademark Office (USPTO) now rejects patents claiming cold fusion. Esther Kepplinger, the deputy commissioner of patents in 2004, said that this was done using the same argument as with perpetual motion machines: that they do not work. Patent applications are required to show that the invention is "useful", and this utility is dependent on the invention's ability to function.
The updated language also clarified that the non-exhaustive list of exempted materials was illustrative in nature, inferring that unlisted materials not yet invented or in wide use at the time of its passage would be prohibited from being subject to sanctions or other regulation under both acts.
=== Insomnia === In all of the reported cases, the need for sleep was severely reduced and in some cases not necessary. The duration of sleep in one case decreased to about 2–4 hours per 24-hour period. Clinical features pertaining to insomnia include daytime drowsiness associated with a loss of ability to sleep, intermingled with confusional oneiric status, and the emergence of atypical REM sleep from wakefulness. The polysomnogram (PSG) picture of this disease is characterized by an inability to generate physiological sleep (key features are the suppression of the hallmarks of stage 2 non-REM sleep: spindles and K complexes) and by the emergence of REM sleep without atonia. The involvement of the thalamus and connected limbic structures in the pathology indicate the prominent role that the limbic thalamus plays in the pathophysiology of sleep. In a case documented in 1974, PSG findings documented the sustained absence of all sleep rhythms for up to a period of 4 months. Electroencephalography (EEG) in one case was dominated by "wakefulness" and “subwakefulness” states alternating or intermingled with short (< 1 min) atypical REM sleep phases, characterized by a loss of muscle atonia. The “subwakefulness” state was characterized by 4–6 Hz theta activity intermingled with fast activity and desynchronized lower voltage theta activity, behaviourally associated with sleep-like somatic and autonomic behavior.
Sources: en.wikipedia.org
The Bradford protein assay (also known as the Coomassie protein assay) was developed by Marion M. Bradford in 1976. It is a quick and accurate spectroscopic analytical procedure used to measure the concentration of protein in a solution. The reaction is dependent on the amino acid composition of the measured proteins. The original paper presenting and revealing the Bradford protein assay is one of the most cited academic papers in history, currently ranking 3rd on the all-time citation list with just over 150,000 citations.
The Healthcare Facilities Accreditation Program (HFAP) is a not-for-profit organization meant to help healthcare organizations maintain their standards in patient care and comply with regulations and the healthcare environment. Headquartered in Chicago, HFAP is an accreditation organization with authority from Centers for Medicare and Medicaid Services. HFAP provides accreditation programs for hospitals, clinical laboratories, ambulatory surgical centers, office based surgery, and critical access hospitals. HFAP also accredits mental health and physical rehabilitation facilities and provides certification for primary stroke centers. HFAP was founded in 1943 by the American Osteopathic Association, a medical organization representing osteopathic physicians.
She initially attempts to use her powers on Jasmine, but learns of Jasmine's ESP and tries to make the latter her pet instead. Despite being mortally wounded by Blitz, Succubus dies transferring her lifeforce to him. During the events of the crossover film Tokusou Sentai Dekaranger vs. Abaranger, Saunaginnan revives Succubus, who is subsequently deleted by Deka Pink and Yellow and Abare Yellow. Succubus Hells is portrayed by Mayu Gamō (蒲生 麻由, Gamō Mayu). Reversian Blitz Hells (リバーシア星人ブリッツ・ヘルズ, Ribāshia Seijin Burittsu Heruzu): The oldest, cruelest, and most powerful of the Hells Siblings who possesses energy-based powers, wields a sword and a machine gun-like blaster, is willing to sacrifice his siblings, and earned a reputation as the "Outer Space Grim Reaper" (宇宙の死神, Uchū no Shinigami). After being defeated by the Dekarangers, he attempts to escape in God Pounder, only to be deleted by Riding Dekaranger Robo. Blitz Hells is voiced by Hiroshi Tsuchida (土田 大, Tsuchida Hiroshi). Tylerian Durden (タイラー星人ダーデン, Tairā Seijin Dāden): The owner and fight promoter of an illegal fight club, gambling operation, and illegal steroid ring from Planet Tyler. After recognizing the Dekarangers while they were infiltrating his fight club, he retaliates by piloting a demon-themed Kaijuki called Ultimate Evil (アルティメットイビル, Arutimetto Ibiru), only to be deleted by Super Dekaranger Robo. Durden is voiced by Masaharu Satō (佐藤 正治, Satō Masaharu).
It noted that TikTok had implemented positive measures, such as forbidding direct messaging for users younger than 16 and allowing their parents to manage privacy settings directly through a paired family account, but the risk of children pretending to be older when creating their account remains. TikTok raised the minimum age for livestreaming from 16 to 18 after a BBC News investigation found hundreds of accounts going live from Syrian refugee camps. Thirty of them showed children begging for digital donation. TikTok reportedly made as much as a 70% commission on some of them, a figure that the company disputed. In March 2024, the Italian Competition Authority fined TikTok €10 million for not protecting underage users adequately from harmful content such as the "French scar" challenge, which left heavy pinch marks on a person's cheeks. On 30 December 2024, Venezuela's Supreme Court fined TikTok $10 million over viral challenges that authorities say led to the deaths of three children. The court cited TikTok's negligence in failing to implement "necessary and adequate measures" to prevent the viral video challenges.
Euthyroid sick syndrome (ESS) is a state of adaptation or dysregulation of thyrotropic feedback control wherein the levels of T3 or T4 are abnormal, but the thyroid gland does not appear to be dysfunctional. This condition may result from allostatic responses of hypothalamus-pituitary-thyroid feedback control, dyshomeostatic disorders, drug interferences, and impaired assay characteristics in critical illness. The classical phenotype of this condition is often seen in starvation, critical illness, or patients in the intensive care unit. Similar endocrine phenotypes are observed in fetal life and in hibernating mammals. The most common hormone pattern in nonthyroidal illness syndrome is low total and free T3, elevated rT3, and normal T4 and TSH levels, although T4 and TSH suppression may occur in more severe or chronic illness. This classical pattern results from type 1 allostatic load, i.e. a stress response resulting from lacking energy, oxygen, and glutathione. An alternative phenotype with a largely inverse hormonal pattern is seen in several physiological and pathological conditions, including pregnancy, obesity, endurance training, and psychiatric diseases. It is typically associated with high-T3 syndrome, increased plasma protein binding of thyroid hormones, and an elevated set point of the homeostatic system. It represents a response to type-2 allostatic load.
Sources: en.wikipedia.org
Bremelanotide binds several melanocortin receptors, and MC4R is the subtype most often cited as responsible for its behavioural effects. Activity at MC1R, MC3R and MC5R is also reported. Selectivity is therefore described as limited rather than precise.
It is not classified as a vasodilator, and its proposed site of action is the central nervous system rather than peripheral vessels. Some trial participants show small transient blood pressure changes. Whether those changes arise centrally or through another route remains an open question.
Most evidence comes from animal models and from indirect human outcomes such as self-reported desire. Direct measurements of receptor occupancy or signalling in the human brain are not available. Published reviews therefore present a plausible pathway rather than a confirmed sequence of events.
Trial results generally show a small to moderate average improvement in desire scores relative to placebo. The distribution of responses is wide, and some participants show little measurable change. Group averages should not be read as a prediction for any single person.